EConsole2

K240243 · DRTECH Corporation · LLZ · Sep 23, 2024 · Radiology

Device Facts

Record IDK240243
Device NameEConsole2
ApplicantDRTECH Corporation
Product CodeLLZ · Radiology
Decision DateSep 23, 2024
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 892.2050
Device ClassClass 2
AttributesSoftware as a Medical Device, Pediatric

Intended Use

EConsole2 is indicated for use in general radiographic images of human anatomy. It is intended to replace radiographic film/screen systems in all general-purpose diagnostic procedures (excluding fluoroscopic, and mammographic applications). It is intended for both adult and pediatric populations.

Device Story

EConsole2 is digital radiography operating console software; integrates with digital X-ray detectors to acquire, process, and manage radiographic images. Operates as an interface for X-ray projection; enables generator control (kVp, mA, mAs settings); supports DICOM connectivity for PACS and printers. Features include image search, storage, annotation, measurement, stitching, and processing. Includes 'ECE' (Exposure Correction Engine) function to normalize image brightness/contrast via linear transformation based on reference points, ensuring uniform image quality regardless of exposure dose. Used by clinicians in diagnostic settings. Benefits include standardized image quality and efficient workflow integration.

Clinical Evidence

No clinical data. Substantial equivalence is supported by non-clinical performance testing, including software verification and validation, and compliance with recognized consensus standards.

Technological Characteristics

Software-based radiological image processing system. Operates on standard hardware platforms. Connectivity via DICOM (NEMA PS 3.1-3.20). Implements ECE function (linear transformation for brightness/contrast normalization). Cybersecurity controls per UL ANSI 2900-1. Software lifecycle processes per IEC 62304.

Indications for Use

Indicated for general radiographic imaging of human anatomy in adult and pediatric populations. Excludes fluoroscopic, angiographic, and mammographic applications.

Regulatory Classification

Identification

A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.

Special Controls

*Classification.* Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue. DRTECH Corporation An Yeong-Suk Assistant Manager Suite No.1, 2 Floor / Suite No. 2, 3 Floor 29, Dunchon-daero 541 beon-gil, Jungwon-gu Seongnam-si, Gyeonggi-do 13216 Korea, South Re: K240243 September 23, 2024 Trade/Device Name: EConsole2 Regulation Number: 21 CFR 892.2050 Regulation Name: Medical Image Management And Processing System Regulatory Class: Class II Product Code: LLZ Dated: August 14, 2024 Received: August 14, 2024 Dear An Yeong-Suk: We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpm/pm.cfm identifies combination product submissions. The general controls of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download). Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and {1}------------------------------------------------ production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181). Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatoryinformation/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050. All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-device-advice-comprehensive-regulatory-assistance/unique-deviceidentification-system-udi-system. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reporting-mdr-how-report-medicaldevice-problems. For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/deviceadvice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuingeducation/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-deviceadvice-comprehensive-regulatory-assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, Jessica Lamb Jessica Lamb, PhD Assistant Director, Imaging Software Team DHT8B: Division of Radiologic Imaging Devices and Electronic Products OHT8: Office of Radiological Health Office of Product Evaluation and Ouality Center for Devices and Radiological Health {2}------------------------------------------------ ### Indications for Use 510(k) Number (if known) K240243 Device Name EConsole2 Indications for Use (Describe) EConsole2 is indicated for use in general radiographic images of human anatomy. It is intended to replace radiographic film/screen systems in all general-purpose diagnostic procedures (excluding fluoroscopic, and mammographic applications). It is intended for both adult and pediatric populations. Type of Use (Select one or both, as applicable) | <span style="font-size: 10pt;"> <span style="font-family: Symbol;">×</span> Prescription Use (Part 21 CFR 801 Subpart D)</span> | |---------------------------------------------------------------------------------------------------------------------------------| | <span style="font-size: 10pt;"> <span>□</span> Over-The-Counter Use (21 CFR 801 Subpart C)</span> | #### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. #### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ RTECH #### DRTECH Corporation Suite No.1, 2 Floor / Suite No. 2, 3 Floor, 29, Dunchon-Daero 541beon-gil, Jungwon-gu, Seongnam-si, Gyeonggi-do, 13216, Republic of Korea ### 510(k) Summary [As required by 21 CFR 807.92] This 510(k) summary of safety and effectiveness information is prepared in accordance with 21 CFR 807.92 ### 1. Date Prepared [21 CFR 807.92(a) (1)] September/20/2024 #### 2. Submitter's Information [21 CFR 807.92(a) (1)] - Name of Sponsor: DRTECH Corporation - Address: Suite No.1, 2 Floor / Suite No. 2, 3 Floor, 29, Dunchon-daero 541 beon-gil, ● Jungwon-gu, Seongnam-si, Gyeonggi-do, 13216, Republic of Korea - Contact Name: Yeongsuk An - + 82-31-779-7787 Telephone No.: ● - Fax No .: + 82-31-779-7790 ● - Email Address : ● drtechra@drtech.com - Registration Number: 3005172103 - Name of Manufacturer: Same as Sponsor ● #### 3. Identification of the Subject Device [21 CFR 807.92(a) (2)] | Model Name: | EConsole2 | |----------------------------|------------------------------------------------| | Common Name: | Radiological Image Processing System | | Classification Name: | Medical image management and processing system | | Classification Panel: | Radiology | | Classification Regulation: | 21 CFR 892.2050 | | Primary Product Code: | LLZ | | Device Class: | II | #### 4. Identification of Predicate Device(s) [21 CFR 807.92(a) (3)] #### 4.1 Predicate device - 510(k) Number: K231225 ● - Applicant: DRTECH Corporation - . Trade Name: EConsole1 - Classification Name: Medical image management and processing system - Classification Panel: Radiology ● - . Classification Regulation: 21 CFR 892.2050 - Product Code: LLZ - Device Class: II ● {4}------------------------------------------------ #### DRTECH Corporation Suite No.1, 2 Floor / Suite No. 2, 3 Floor, 29, Dunchon-Daero 541beon-gil, Jungwon-gu, Seongnam-si, Gyeonggi-do, 13216, Republic of Korea #### 5. Description of the Device [21 CFR 807.92(a) (4)] EConsole2 is digital radiography operating console software. EConsole2 provides an integrated solution for X-ray projection. It integrates with the digital detector. Furthermore, EConsole2 acquires and processes images. In addition, it complies with DICOM standards and is able to transmit and receive data with the PACS system, and print images through the DICOM printer. #### 6. Indication for Use [21 CFR 807.92(a)(5)] EConsole2 is indicated for use in general radiographic images of human anatomy. It is intended to replace radiographic film/screen systems in all general-purpose diagnostic procedures (excluding fluoroscopic, angiographic, and mammographic applications). It is intended for both adult and pediations. #### 7. Technological Characteristics [21 CFR 807.92(a)(6)] The EConsole2 is a x-ray image software device. It can utilize and transfer the digitalizing x-ray images for radiography diagnostic. It can work with Modality worklist, PACS and DICOM Printer to maintain the patient information and the images from flat panel detector. {5}------------------------------------------------ # DRTECH #### 8. Substantial Equivalence Comparison [21 CFR 807.92(b)] | Parameter | Proposed Device | Predicate Device | Equivalence<br>Analysis | |------------------------------|------------------------------------------------|------------------------------------------------|-------------------------| | 510(k) Number | Unknown | K231225 | N/A | | Model Name | EConsole2 | EConsole1 | N/A | | Manufacturer | DRTECH Corporation | DRTECH Corporation | N/A | | Common Name | Radiological Image Processing System | Radiological Image Processing System | N/A | | Classification Name | Medical image management and processing system | Medical image management and processing system | N/A | | Classification Panel | Radiology | Radiology | Equivalence | | Classification<br>Regulation | 21 CFR 892.2050 | 21 CFR 892.2050 | Equivalence | | Product Code | LLZ | LLZ | Equivalence | | Device Class | Class II | Class II | Equivalence | {6}------------------------------------------------ Image /page/6/Picture/1 description: The image shows the word "DRTECH" in blue font. The letters are spaced apart and are all capitalized. The font is simple and sans-serif. | Intended Use | EConsole2 is indicated for use in general radiographic<br>images of human anatomy. It is intended to replace<br>radiographic film/screen systems in all general-<br>purpose diagnostic procedures (excluding<br>fluoroscopic, angiographic, and mammographic<br>applications). It is intended for both adult and<br>pediatric populations. | EConsole1 is indicated for use in general<br>radiographic images of human anatomy. It is<br>intended to replace radiographic film/screen<br>systems in all general-purpose diagnostic<br>procedures (excluding fluoroscopic, angiographic,<br>and mammographic applications). | Similar | | |-------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------| | Software Function | Image acquisition and study<br>Image search<br>Image storage<br>Image annotation<br>Image measurement<br>Image stitch<br>Image processing<br>Generator Control | Image acquisition and study<br>Image search<br>Image storage<br>Image annotation<br>Image measurement<br>Image stitch<br>Image processing<br>Generator Control | Similar | | | DICOM Compliance | Yes | Yes | Equivalence | | | Software Function | | Technological characteristics | | Equivalence<br>Analysis | | | | Proposed Device(Non) | Predicate Device(K231225) | | | Generator Control | | This function controls the generator to set X-ray<br>irradiation conditions(such as kVp, mA, mAs, etc.) can<br>be adjusted. And this function transmit the set data to the<br>generator. Then It is displayed the set X-ray irradiation<br>conditions, and displays the image acquired after X-ray<br>irradiation. | This function controls the generator to set X-ray<br>irradiation conditions(such as kVp, mA, mAs, etc.)<br>can be adjusted. And this function transmit the set<br>data to the generator. Then It is displayed the set<br>X-ray irradiation conditions, and displays the<br>image acquired after X-ray irradiation. | Equivalence | | | | But this control function of EConsole2 does not exerts<br>control over generator power that produces ionizing<br>radiation. However, Its does not have control over<br>exposure, electrical changes, or the calibration of the X-<br>ray system. | But this control function of EConsole2 does not<br>exerts control over generator power that produces<br>ionizing radiation. However, Its does not have<br>control over exposure, electrical changes, or the<br>calibration of the X-ray system. | Equivalence | | DEXi Function | | 1. When generator which supports DEXi and when<br>examining DEXi, mark the irradiation condition(High<br>kV, High mA, High mAs, Low kV, Low mA, Low mAs)<br>and provide button to control the irradiation condition.<br>2. When changing the irradiation condition, connect with<br>generator and control the irradiation condition. | 1. When generator which supports DEXi and when<br>examining DEXi, mark the irradiation<br>condition(High kV, High mA, High mAs, Low kV,<br>Low mA, Low mAs) and provide button to control<br>the irradiation condition.<br>2. When changing the irradiation condition,<br>connect with generator and control the irradiation<br>condition. | Equivalence | | | Truveiw ART | Increase the sharpness of the obtained x-ray images. | Increase the sharpness of the obtained x-ray<br>images. | Equivalence | | Image<br>Processing(Optional) | ECE Function | ECE function can be applied before the main image<br>processing. This function normalizes the image<br>brightness and contrast regardless of the exposed x-ray<br>dose.<br>ECE function works as a simple linear transformation to<br>each pixel value.<br>To find the slope and the offset of the linear function,<br>ECE function first finds two or more reference points in<br>the radiograph. The reference points are selected<br>depending on the body part and position of the patient.<br>By using these reference points, we can determine the | N/A | This is new<br>function of<br>EConsole2. | When compared to the predicate devices (K23125), the device proposed in this submission, the followings as the predicate device and reference device: - Intended Use - Software function - Technological characteristics {7}------------------------------------------------ # DRTECH In case of Technological characteristics, all items are the same, but some items have detailed optional functions. Please refer to the below table. {8}------------------------------------------------ # DRTECH | slope and the offset of the linear function.<br>Finally, by using the inverse of the linear function, the<br>brightness and the contrast of the radiograph will be<br>normalized even with different x-ray exposure condition.<br>And now some desired function, such as gamma<br>correction or LUT, can be applied.<br>With ECE function, the main image processing engine<br>can expect an image with similar brightness and contrast<br>regardless of the x-ray exposure condition. Therefore, the<br>resulting radiograph will have more uniform image<br>quality.<br>The user cannot change the parameters of this function or<br>turn it off. Only the engineers can change. And this<br>function is used for all of the body parts including chest,<br>abdomen, pelvis, skull, extremities and etc. | | | |------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--|--| |------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--|--| {9}------------------------------------------------ ## DRTECH #### 9. Summary of Non-Clinical Data [21 CFR 807.92(b)(1)] The EConsole2 complies with the following international and FDA-recognized consensus standards list in Table 2. | Recognition No. | Standard No. | Title of Standard | Remark | |-----------------|--------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------|--------| | 13-79 | IEC 62304 Edition 1.1 2015-06<br>CONSOLIDATED VERSION | Medical device software - Software<br>life cycle processes | | | 13-129 | ISO IEC IEEE 29119-1 First<br>edition 2013-09-01 | Software and systems engineering -<br>Software testing - Part 1: Concepts<br>and definitions | | | 12-349 | NEMA PS 3.1 - 3.20 2022d | Digital Imaging and<br>Communications in Medicine<br>(DICOM) Set | | | 5-135 | ISO 20417 First edition 2021-04<br>Corrected version 2021-12 | Medical devices - Information to be<br>supplied by the manufacturer | | | 5-129 | IEC 62366-1 Edition 1.1 2020-<br>06 CONSOLIDATED<br>VERSION | Medical devices - Part 1:<br>Application of usability<br>engineering to med | | | 5-125 | ISO 14971 Third Edition 2019-<br>12 | Medical devices - Application of<br>risk management to medical device | | | 13-96 | UL ANSI 2900-1 First Edition<br>2017 | Standard for Safety, Standard for<br>Software Cybersecurity Network-<br>Connectable Products, Part 1:<br>General Requirements | | | | Table 2. International and FDA-recognized consensus standards | | |--|---------------------------------------------------------------|--| | | | | And EConsole2 comply with the FDA guidance documents listed in Table 3. Table 3. FDA Guidance Documents | Title of Guidance Document | Issue Date | |-------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------| | Guidance for Industry and Food and Drug Administration Staff: The 510(k)<br>Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)] | July 28, 2014 | | Content of Premarket Submissions for Device Software Functions, Guidance for<br>Industry and Food and Drug Administration Staff | June 14, 2023 | | Off-The-Shelf Software Use in Medical Devices | August 11, 2023 | {10}------------------------------------------------ #### DRTECH Corporation Suite No.1, 2 Floor / Suite No. 2, 3 Floor, 29, Dunchon-Daero 541beon-gil, Jungwon-gu, Seongnam-si, Gyeonggi-do, 13216, Republic of Korea | Title of Guidance Document | Issue Date | |-----------------------------------------------------------------------------------------------------------------------------------------|--------------------| | Cybersecurity in Medical Devices Quality System Considerations and Content of<br>Premarket Submissions | September 26, 2023 | | Pediatric Information for X-ray Imaging Device Premarket Notifications,<br>Guidance for Industry and Food and Drug Administration Staff | November 28, 2017 | The risk analysis was completed and risk controls were implemented to mitigate identified hazards. The test results support that all the specifications have met the acceptance criteria. Verification and validation testing were found acceptable to support the claim of substantial equivalence. #### 10. Summary of Clinical Data [21 CFR 807.92(b)(2)] #### Not Applicable Clinical studies are unnecessary to validate the safety and effectiveness of the Radiological Image Processing System, EConsole2, the subject of this 510(k) notification. #### 11. Conclusion [21 CFR 807.92(b)(3)] The EConsole2 is substantially equivalent to the currently marketed predicate device (K231225, EConsole1) in terms of technical characteristics, general function, applications for use, safety, and effectiveness. Substantial equivalence for Radiological Image Processing System (EConsole2) was demonstrated through the non-clinical performance in compliance with the requirements specified in the international and FDA recognized consensus standards, IEC 62366-1, and UL ANSI 2900-1. The comparison of technological characteristics, non-clinical performance data and safety testing demonstrate that the EConsole 2 is substantially equivalent to the predicate devices.
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%